thromboxanes has been researched along with Anti-Phospholipid Antibody Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnout, J; de Groot, PG; Derksen, RH; Lenting, PJ; Lutters, BC; Tekelenburg, WL | 1 |
Alekberova, ZS; Aleksandrova, EN; Kalashnikova, LA; Kubatiev, AA; Mach, ZS; Nasonov, EL; Reshetniak, TM; Rud'ko, IA; Sushkevich, GN | 1 |
2 other study(ies) available for thromboxanes and Anti-Phospholipid Antibody Syndrome
Article | Year |
---|---|
Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'.
Topics: Antibodies, Monoclonal; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Blood Platelets; Cell Adhesion; Collagen; Dimerization; Female; Fibrinogen; Fibronectins; Glycoproteins; Humans; LDL-Receptor Related Proteins; Ligands; Microscopy, Fluorescence; Perfusion; Phospholipids; Platelet Aggregation; Precipitin Tests; Protein Binding; Receptors, LDL; Receptors, Lipoprotein; Signal Transduction; Thromboxanes; Transfection | 2003 |
[Levels of thromboxane and prostacyclin in patients with systemic lupus erythematosus and antiphospholipid syndrome].
Topics: Adult; Antiphospholipid Syndrome; Epoprostenol; Female; Humans; Lupus Erythematosus, Systemic; Male; Pregnancy; Pregnancy Complications; Risk Factors; Syndrome; Thrombocytopenia; Thrombosis; Thromboxanes | 1994 |